Skip to content
Buchalter
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Attorneys
  • Practices & Industries
  • Thought Leadership
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
    • Videos
    • Podcasts
  • News & Events
    • News
    • Events/
      Speaking Engagements
  • Payment Portal
    • Pay your invoice
    • Pay your retainer
  • Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Videos
    • Podcasts
    • Publications
    • Chemical Law & Prop 65 Blog
    • Webinars
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
« View All News

Buchalter Shareholder Frank X. Curci Re-Elected to Cancer Research And Biostatistics’ Board of Directors

Frank X. Curci, a Shareholder at the Buchalter law firm in its Portland and Scottsdale offices, was recently re-elected as a Director on the Board of Directors of Cancer Research And Biostatistics (“CRAB”). Curci has been a Director at CRAB since 2012 and serves on the Board’s Strategic Planning Committee.

CRAB is a nonprofit bioscience organization based in Seattle, Washington. CRAB's mission is to help conquer cancer and other diseases by participating in all aspects of the design, conduct, and analysis of clinical trials. Recognized internationally, CRAB provides biostatistical and other clinical trial expertise to support cancer research.

Share

Related Attorneys

  • Frank X. Curci

Adam Bass, Buchalter President & CEO

  • About
  • Careers
  • News & Events
  • Subscribe
  • Atlanta
  • Chicago
  • Denver
  • Los Angeles
  • Napa Valley
  • Nashville
  • Orange County
  • Portland
  • Sacramento
  • Salt Lake City
  • San Diego
  • San Francisco
  • Scottsdale
  • Seattle
  • © Copyright 2025 Buchalter, A Professional Corporation
  • Privacy Notice
  • Notice at Collection
  • Do Not Sell or Share PI
  • Tenrec Logo